Adults over 50 Intrinsic factor production declines with age
The future of obesity benefits: 5 trends employers need to know beyond GLP-1s Discover five obesity care trends shaping employer benefits, from personalized treatment and GLP-1 innovation to behavior change and long-term health outcomes
Elevated androgens in PCOS drive acne, facial hair growth, and scalp hair thinningall driven partly by insulin dysregulation
Conclusion The interrelationship between PsD and its metabolic comorbidities namely obesity, T2DM, and CV disease is increasingly recognized as a critical determinant of patient outcomes requiring multidisciplinary management
Read in Daily Maverick : In the grip of obesity and a lifetime of self-loathing, Ozempic is the Holy Grail The start of the journey In the 19th century, French physiologist Claude Barnard sought to explain why large amounts of glucose (the main sugar in your blood) can be taken orally, whereas if glucose is given intravenously, small amounts overload the bodys systems
